Associated Medical Conditions for Psoriasis

The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Percent Est Matches Bacteria in From Bacteria in To
Allergies 28.3 % 13 50 46
Alzheimer's disease 30.4 % 14 50 46
Autism 41.3 % 19 110 46
Ulcerative colitis 45.7 % 21 108 46
Rosacea 22.7 % 5 22 46
Schizophrenia 21.7 % 10 93 46
Multiple Sclerosis 34.8 % 16 100 46
Ankylosing spondylitis 52.2 % 24 520 46
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 43.5 % 20 134 46
Obesity 21.7 % 10 55 46
Obesity 26.1 % 12 104 46
Amyotrophic lateral sclerosis (ALS) Motor Neuron 11.6 % 5 43 46
Osteoporosis 22.7 % 5 22 46
ME/CFS with IBS 21.1 % 4 19 46
ME/CFS without IBS 19.2 % 5 26 46
Multiple system atrophy (MSA) 14.3 % 3 21 46
Metabolic Syndrome 28.6 % 2 7 46
Systemic Lupus Erythematosus 21.7 % 10 66 46
Liver Cirrhosis 58.7 % 27 678 46
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 17.4 % 8 76 46
Parkinson's Disease 19.6 % 9 90 46
Chronic Kidney Disease 17.1 % 6 35 46
Insomnia 40 % 4 10 46
Depression 19.6 % 9 81 46
Irritable Bowel Syndrome 21.7 % 10 62 46
Chronic Urticaria (Hives) 34.8 % 8 23 46
IgA nephropathy (IgAN) 10.3 % 3 29 46
Hyperlipidemia (High Blood Fats) 16 % 4 25 46
hypertension (High Blood Pressure 50 % 3 6 46
hypercholesterolemia (High Cholesterol) 22.2 % 2 9 46
gallstone disease (gsd) 40 % 6 15 46
Graves' disease 12.5 % 1 8 46
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 12.5 % 3 24 46
Fibromyalgia 10.8 % 4 37 46
Functional constipation / chronic idiopathic constipation 24.4 % 10 41 46
Gout 14.3 % 3 21 46
Epilepsy 24 % 6 25 46
Cerebral Palsy 52.9 % 9 17 46
Inflammatory Bowel Disease 34.8 % 16 66 46
Type 1 Diabetes 19.6 % 9 52 46
cystic fibrosis 14.3 % 1 7 46
COVID-19 13.9 % 5 36 46
Carcinoma 21.7 % 10 51 46
Colorectal Cancer 26.1 % 12 296 46
Celiac Disease 13 % 6 67 46
Chronic Fatigue Syndrome 13 % 6 55 46
Crohn's Disease 47.8 % 22 141 46
Coronary artery disease 12.5 % 2 16 46
Generalized anxiety disorder 14.3 % 2 14 46
Bipolar Disorder 24.2 % 8 33 46
Asthma 22.2 % 6 27 46
Atherosclerosis 47.8 % 22 524 46
Acne 31.6 % 6 19 46
Stress / posttraumatic stress disorder 28.3 % 13 56 46
Small Intestinal Bacterial Overgrowth (SIBO) 25 % 4 16 46
Sjögren syndrome 22 % 9 41 46
Type 2 Diabetes 56.5 % 26 267 46
ADHD 13 % 6 47 46
Hashimoto's thyroiditis 14.3 % 2 14 46

(Legacy User)

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2021 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA